Brown Hearing Health Services Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 451 Hidden Meadows Dr, Suite 240, Hillsdale, MI 49242 Phone: 517-437-8366 Fax: 517-279-6119 |
Sandra Jean Hepker, MS Audiologist Medicare: May Accept Medicare Assignments Practice Location: 67 East Saint Joe Street, Professional Hearing Services, Hillsdale, MI 49242 Phone: 517-439-1610 Fax: 517-439-5679 |
News Archive
A natural compound called limonene, which is found in oranges and lemons, could be indicative in early-stage diagnosis of liver disease, according to research published in the journal EBioMedicine by researchers in the Molecular Physics Group at the University of Birmingham.
KemPharm, Inc. today announced that it has commenced a Phase 1 clinical trial in healthy volunteers of its novel prodrug compound, KP106, which is in development for the treatment of attention-deficit hyperactivity disorder (ADHD). KP106, a new chemical entity (NCE) composed of d-amphetamine and a ligand, is the lead investigational candidate from KemPharm's proprietary ligand activated therapy (LAT) platform, which creates improved versions of FDA-approved drugs. KemPharm began the KP106 program in 2007 and has initiated the Phase 1 clinical trial of this candidate in less than 24 months.
Improvements in critical care and decreased use of blood transfusions over the course of the last decade are associated with decreases in the rate, severity and risk of death from post-injury multiple organ failure, according to a study in the May issue of Archives of Surgery.
Cells can produce unique electrical signals. These signals can be linked to various cancers, such as the breast, lung, liver, brain, pancreas and prostate cancers, meaning that they can be used as indicators for early cancer diagnosis.
› Verified 6 days ago